Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Literature DB >> 7137987

In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Abstract

The antibiotic susceptibilities of 16 clinical isolates of Aeromonas hydrophila obtained from cancer patients with septicemia were studied. Of the new beta-lactam antibiotics tested, azthreonam and moxalactam were the most active, followed by cefoperazone, cefotaxime, and ceftizoxime. Excellent activity was demonstrated by chloroamphenicol, tetracycline, aminoglycosides, and trimethoprim-sulfamethoxazole. Semisynthetic penicillins had no appreciable activity against this organism.

Entities: Chemical Disease Species

Mesh：

Substances：
Anti-Bacterial Agents

Year: 1982 PMID： 7137987 PMCID： PMC183774 DOI： 10.1128/AAC.22.3.513

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

6 in total

1. In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.

Authors: R J Fass; J Barnishan
Journal: Antimicrob Agents Chemother Date: 1981-02 Impact factor: 5.191

2. Comparative in vitro study of SQ26,776.

Authors: V Fainstein; S Weaver; G P Bodey
Journal: Antimicrob Agents Chemother Date: 1982-02 Impact factor: 5.191

3. Antimicrobial susceptibility of Aeromonas hydrophila.

Authors: T L Overman
Journal: Antimicrob Agents Chemother Date: 1980-04 Impact factor: 5.191

Review 4. Human aeromonas infections: a review of the literature and a case report of endocarditis.

Authors: W A Davis; J G Kane; V F Garagusi
Journal: Medicine (Baltimore) Date: 1978-05 Impact factor: 1.889

5. In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.

Authors: R J Fass
Journal: Antimicrob Agents Chemother Date: 1980-09 Impact factor: 5.191

6. Aeromonas hydrophila bacteremia in ambulatory immunocompromised hosts.

Authors: R L Wolff; S L Wiseman; C S Kitchens
Journal: Am J Med Date: 1980-02 Impact factor: 4.965

6 in total

20 in total

1. Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan.

Authors: W C Ko; K W Yu; C Y Liu; C T Huang; H S Leu; Y C Chuang
Journal: Antimicrob Agents Chemother Date: 1996-05 Impact factor: 5.191

2. Activity of newer antimicrobial agents against Aeromonas hydrophila.

Authors: K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal: Eur J Clin Microbiol Date: 1986-08 Impact factor: 3.267

3. In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.

Authors: J M Koehler; L R Ashdown
Journal: Antimicrob Agents Chemother Date: 1993-04 Impact factor: 5.191

4. Aeromonas hydrophilia tenosynovitis in an immunocompromised host.

Authors: R P Warrier; S Azeemuddin
Journal: Indian J Pediatr Date: 1984 Sep-Oct Impact factor: 1.967

5. Antimicrobial susceptibility patterns of Aeromonas jandaei, A. schubertii, A. trota, and A. veronii biotype veronii.

Authors: T L Overman; J M Janda
Journal: J Clin Microbiol Date: 1999-03 Impact factor: 5.948

Review 6. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors: D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1984-06 Impact factor: 9.546

7. Unusual case of Aeromonas hydrophila endocarditis.

Authors: K R Ong; E Sordillo; E Frankel
Journal: J Clin Microbiol Date: 1991-05 Impact factor: 5.948

8. Seasonal incidence of and antibiotic resistance among Aeromonas species isolated from domestic wastewater before and after treatment in stabilization ponds.

Authors: L Hassani; B Imziln; A Boussaid; M J Gauthier
Journal: Microb Ecol Date: 1992-05 Impact factor: 4.552

9. Plasmids and resistance to antimicrobial agents in Aeromonas sobria and Aeromonas hydrophila clinical isolates.

Authors: B J Chang; S M Bolton
Journal: Antimicrob Agents Chemother Date: 1987-08 Impact factor: 5.191

Review 10. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors: R N Brogden; R C Heel
Journal: Drugs Date: 1986-02 Impact factor: 9.546